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Purpose: The present study was conducted to develop a mild vascular cognitive impairment (MVCI)
assessment tool for patients with stroke and to examine its validity, reliability, and clinical adequacy.
Methods: Items of this tool were developed based on previously veriﬁed cognitive assessment tools. Face,
content, and criterion (concurrent) validities, optimal cut-off score for differentiation of MVCI and
normal cognitive function, clinical adequacy, internal consistency, and inter-rater reliability of the
assessment tool were determined in 60 stroke patients at a university hospital located in Incheon, South
Korea.
Results: The devised MVCI assessment tool contains 20 items which were designed to assess seven
cognitive domains: orientation, memory, language, attention, reasoning/abstraction, visuospatial
perception, and executive function/problem solving. Content, face, and construct validities were well
supported. Clinical adequacy testing revealed that the overall probability of correctly discriminating
MVCI using the MVCI assessment tool for stroke was 90.0%, which was statistically signiﬁcant.
Furthermore, a score of 23 was found to be the optimal cut-off score for MVCI. Internal consistency and
inter-rater reliability were also well supported.
Conclusions: The ﬁndings of this study indicate that the developed MVCI assessment tool for stroke could
serve as a clinically useful tool for detecting MVCI and for properly assessing degree of cognitive
impairment in stroke patients.
Copyright © 2015, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Vascular cognitive impairment is a spectrum of cognitive im-
pairments caused by various diseases, such as hypertension, dia-
betes, arteriosclerosis, transient ischemic attack, and stroke [1].
Stroke is one of the most common causes of vascular cognitive
impairment [2]. The term cognitive impairment covers a wide va-
riety of conditions ranging from the mildest form of cognitive
impairment to overt dementia [1,3e5]. Poststroke cognitive
impairment may lead to dementia (vascular dementia), but it often
exhibits mild deﬁciencies in cognitive function (mild vascular
cognitive impairment; MVCI) [6], which is referred to as “vascular
cognitive impairment, no dementia”. Despite great differences be-
tween studies, the highest incidence rate of 64.0% for MVCI amongrtment of Nursing, College of
eon, 22212, South Korea.
ciety of Nursing Science. Publishedstroke survivors was reported by Jin, Di Legge, Ostbye, Feightner,
and Hachinski [7]. Few studies have been conducted on the MVCI
incidence rate in Korea. Only one study reported an incidence rate
of 39.0% (n ¼ 156) for mild cognitive impairment among 396
Korean stroke patients [8].
According to Wentzel et al [9], approximately half of patients
withMVCI develop dementia within 5 years of stroke. The common
cognitive domains associated with MVCI in stroke patients are
short-term memory (31.0%), long-term memory (23.0%), visuo-
spatial ability (37.0%), executive functions (25.0%), and language
(14.0%) [10]. In addition, MVCI following stroke has been shown to
be signiﬁcantly associated with early death and decrease in quality
of life for patients and their families [6].
The assessment of MVCI is important because the early detec-
tion of cognitive impairment may facilitate intervention targeting
the prevention of dementia in stroke patients [11,12]. In addition,
proper assessment can provide precise information to stroke pa-
tients and their families, and enable the development of effective
cognitive rehabilitation plans that improve outcomes and quality ofby Elsevier. All rights reserved.
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ment tool is important for the establishment of nursing care and
rehabilitation plans for stroke patients.
Backgrounds
It has been consistently reported that MVCI occurs frequently in
patients with stroke [13,14]. According to Nys, van Zandvoort, de
Kort, Jansen, de Haan, and Kappelled [15], a high proportion of
stroke survivors develop MVCI within 3 months of stroke, espe-
cially if the cerebral cortex is involved (74.0%). Patients suffering
from vascular dementia often present with cognitive decline and
memory impairment severe enough to interfere with daily activ-
ities [1]. On the other hand, MVCI is characterized by slight
cognitive impairments in only a few cognitive domains and does
not signiﬁcantly impact daily functioning [16e18]. Nevertheless,
MVCI may lead to dependence on others for daily activities,
adversely affects patient quality of life, and increases family burden
[6].
Of the cognitive domains, executive functioning and visual
perception are most commonly associated with MVCI, and short-
term and long-term memory, attention, and language are also
frequently involved [15]. Furthermore, it has been reported that the
severities of deﬁcits in executive functioning, language, verbal
memory, and abstract reasoning are more pronounced following
left than right cortical stroke [15].
Investigators have consistently asserted no consensus has been
reached regarding the deﬁnition of mild cognitive impairment, and
that the boundary between normal cognitive function and mild
cognitive impairment has not been clearly deﬁned [18,19]. How-
ever, distinguishing between pathological mild cognitive impair-
ment and normal cognitive function is important when
determining therapeutic options [18].
The Mini-Mental State Examination (MMSE) is the test most
widely applied to screen cognitive impairment in clinics [20].
However, although the MMSE has been shown to be useful for
screening Alzheimer's type dementia, it is inadequate for evalu-
ating mild cognitive impairment because of its insensitivity to vi-
suospatial and executive functional deﬁcits [21e23].
The Cambridge Examination for Mental Disorders of the Elderly
(CAMCOG) was originally designed to diagnose primary degener-
ative dementia. This test has the advantage that it covers a broader
range of cognitive functions than other tests do [24], and has been
shown to be a more accurate screening tool than the MMSE,
especially for elderly stroke patients [24]. However, little is known
about the diagnostic value of the CAMCOG for MVCI screening.
The Telephone Interviews for Cognitive Status (TICS) was
initially developed to assess cognitive function in elderly patients
with Alzheimer's type dementia. The TICS is a brief test (takes 5e10
minutes) and known to be sensitive and speciﬁc [25]. However, this
test was considered unsuitable for screening MVCI following stroke
because it covers only orientation, memory, attention, and lan-
guage domains of cognitive function [25].
The Montreal Cognitive Assessment (MoCA) tool, which was
recently introduced, was developed to detect mild cognitive
impairment, and has been shown to be more sensitive for detecting
mild cognitive impairment than the MMSE [11,26]. The MoCA in-
cludes several cognitive domains that have been reported to be
most commonly associated with MVCI following stroke in clinical
research studies, and several studies have conﬁrmed its high
sensitivity and speciﬁcity and determined optimal cut-off values by
receiver operating characteristic (ROC) curve analysis [27]).
Furthermore, the MoCA has been translated into 36 languages
including Korean and Chinese, and is now the most popular
cognitive screening tool for detecting mild cognitive impairment[28]. The greatest advantage of the MoCA is its ability to discrimi-
nate between patients with mild cognitive impairment and pa-
tients with dementia or healthy controls [29]. In addition, theMoCA
is a brief, simple tool that can be applied within 10 minutes and
placesmore emphasis on visuo-motor-speed and executive abilities
than other tools do [30].
Based on a review of related literature, we considered the MoCA
to be the most suitable measure for screening mild type cognitive
impairment. However, the MoCA was unlikely to be used for long-
term follow-up examinations and repeated measures because it
includes many items that require evaluations of animal pictures or
naming cards in a face-to-face manner. In addition, the MoCA does
not contain items that assess problem-solving ability, one of the
most common cognitive domains associated with MVCI in stroke
patients [31]. Accordingly, we recognized the need for MVCI
assessment tool which addresses major cognitive domains associ-
ated with stroke and can be administered using diverse approaches
including face-to-face and telephone-based administrations.
Study purpose
The present study was conducted to develop and verify a MVCI
assessment tool for Korean stroke patients. The speciﬁc study aims
were (1) to review other cognitive assessment tools and develop
qualiﬁed items sensitive to MVCI that are capable of identifying the
speciﬁc cognitive domains involved and applicable using different
approaches (face-to-face and telephone interviews) for long-term
follow-up examinations; (2) to evaluate the content and criterion
validities of the MVCI assessment tool for stroke; (3) to conduct
ROC curve analysis to examine construct validity and clinical ade-
quacy by determining an optimal cut-off for differentiation of MVCI
and normal cognitive function, and (4) to evaluate the reliability
(internal and inter-rater reliability) of the MVCI assessment tool for
stroke.
Methods
Study design
The present study adopted a nonexperimental, cross-sectional
correlation design to develop a MVCI assessment tool for stroke
and examine its validity and reliability.
Item development procedure
Developing a brief, simple MVCI assessment tool that can be
administered in different ways was the prime goal of the present
study. As a preliminary step, we reviewed the literature regarding
cognitive impairment after stroke. In particular, an extensive liter-
ature review on previously veriﬁed cognitive assessment tools able
to assess diverse cognitive domains was performed. Finally four
cognitive assessment tools of fair quality were identiﬁed with
simple and brief features (completed within 5e10 minutes without
professional aid). These were MMSE (Korean version), CAMCOG,
TICS, and MoCA (Korean version).
The MMSE uses simple tasks to assess a number of cognitive
domains: orientation, memory, attention, language, and complex
demands. Orientation tasks measure sense of current year, month,
date, day of the week, and season. Memory tasks assess ability to
repeat the names of three objects, which are spoken by an exam-
iner at a rate of one per second, immediately (registered memory)
and after a set time (delayed memory). Attention tasks measure the
ability to count by subtracting 7 from 100. Language tasks assess
the ability to name an object, repeat a given phrase/sentence,
follow a three-stage command as written, read and repeat a given
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Complex demand tasks measure the ability to copy two intersect-
ing pentagons.
The CAMCOG assesses orientation, language (comprehension
and expression), memory (remote, recent, and new learning
memory), attention and calculation, praxis, abstract thinking, and
perception (tactile and visual recognition, unusual view, and per-
son recognition). Individual tasks in each domain of the CAMCOG
are similar to those in the MMSE.
The TICS was developed for use in situations unsuitable for in-
person cognitive screening. This test was originally designed for
administration by telephone, but it can also be administered face-to-
face. The cognitive domains tested by the TICS are orientation,
memory, attention, and language. Orientation tasks consist of ques-
tions about current time, age, and address. Memory tasks measure
abilities to repeat 10 words immediately and after a set time, and to
recall recent and long-termmemories. Attention tasks assess ability
to count by subtracting 7 from100, and to repeat numbers spokenby
an examiner in reverse order. Language tasks measure sentence
repetition, verbal ﬂuency, and comprehension abilities.
The MoCA assesses visuospatial perception, executive functions,
language, memory, attention, abstraction, and orientation. Visuo-
spatial perceptions and executive functions are assessed simulta-
neously using a trail making task (drawing a line from letters to
numbers), a clock-drawing task (drawing the contour of a clock and
positioning numbers and hands to tell the commanded time), and a
cube coping task. The language tasks consist of questions asking the
names of animals on drawing cards (vocabulary), to repeat a sen-
tence (repetition), and to recite more than 11 objects that can be
purchased at a market (ﬂuency). Memory tasks assess ability to
repeat ﬁve words spoken by an examiner immediately (no point
awarded) and after a set time. Attention tasks assess the ability to
repeat ﬁve numbers in the order named, to repeat another three
numbers in reverse order, to count by subtracting 7 from 100, and
to tap every time an the examiner says the letter “A”. Abstraction
tasks assess ability to explainwhat pairs of words have in common.
Orientation tasks measure the sense of current year, month, date,
day of week, and place.
Taken together, it was found that cognitive domains and tasks
included in the four assessment tools were fairly similar (Table 1):
orientation, memory, language, attention, reasoning/abstractTable 1 Cognitive Domains and Tasks Included in Previously Veriﬁed Cognitive Assessment
Domains Assessment tools
Orientation MMSE
CAMCOG
TIC
MoCA
e Ask to tell cu
Memory MMSE
CAMCOG
TICS
MoCA
e Ask to imme
e Ask to repeat
Language MMSE
CAMCOG
TICS
MoCA
e Ask to recite
e Ask to repeat
e Ask to tell na
e Ask to listen
Attention MMSE
CAMCOG
TICS
MoCA
e Ask to repeat
e Ask to count
e Ask to clap w
Reasoning/Abstraction CAMCOG
MoCA
e Ask to explai
Visuospatial perception CAMCOG
MoCA
e Ask to copy a
e Ask to correc
e Ask to draw
Executive function MoCA e Ask to count
Note. CAMCOG ¼ the cambridge examination for mental disorders of the elderly; M
TICS ¼ telephone interviews for cognitive status.thinking, and visuospatial perception. Furthermore, they cover
most of the common cognitive domains known to be associated
with MVCI, that is short-term and long-term memory, attention,
language, executive functioning, and visuospatial perception
[15e17]. However, it was noted only the MoCA contains items that
assess executive functioning.
Based on the ﬁndings of the review, we developed the MVCI
assessment tool for stroke. The tool comprises seven cognitive
domains of orientation, memory, language, attention, reasoning/
abstraction, visuospatial perception, and executive function/prob-
lem solving (Table 2). In particular, we devised an item to assess
executive function/problem solving based on empirical evidence
that the severities of deﬁcits in more complicated cognitive abili-
ties, such as, problem solving, are more pronounced following
stroke [31].
The orientation domain of the MVCI assessment tool for stroke
consists of 6 items that request current date, day of the week,
season, phone number, address, and age (1 point for each; 6
possible points). The memory domain consists of 5 items (imme-
diate, remote/recent, prospect, and delayed memory), based on
other cognitive assessment tools. No score was given for the item
addressing immediate memory (repeat ﬁve words spoken by an
examiner after 30 seconds), as is the case for other cognitive
assessment tools. The possible maximum score of the memory
domain is 8 points: 1 point for remote; 1 point for recent; 1 point
for prospect; and 5 points for delayed memory (1 point for each
word of ﬁve which were spoken by an examiner during immediate
memory testing). Three items were devised for language (repeti-
tion, verbal ﬂuency, and comprehension) based on the other
cognitive assessment tools (1 point for each; 3 possible points). To
assess attention, 3 items were devised (6 possible points):
repeating ﬁve numbers spoken by an examiner (1 point), counting
backwards from 20 (1 point), and counting by subtracting 7 from
100 (4 possible points; 1 point for each number, i.e., 93, 86, 79, and
72 in sequence). Two items were devised to assess reasoning/
abstraction (1 point for each) and 1 item (1 point) was devised to
assess visuospatial perception.
For executive function/problem solving ability domain, 1 item
was devised. This item was designed to assess ability to manage a
given situation using a 4-point scale where 1 represented no idea
what to do to solve the problem (0 points), 2 represented aTools.
Tasks or assessment items
rrent date, day of the week, season, age, telephone number, & address
diately repeat ﬁve words spoken by an examiner
the ﬁve words after all other tests are completed
more than three words that start with the letter “A”
a sentence that is difﬁcult to pronounce
mes of animals on drawing cards or after listening to descriptions of the animals
to short sentences & answer questions
ﬁve numbers spoken by an examiner
backwards from 20
henever an examiner says days of the week in the correct sequence
n what each pair of words has in common (bicycles-train or rose-lily)
drawing of a cube
tly draw a clock showing the time stated by an examiner
a line from letters to numbers (trail making)
by subtracting 7 from 100
MSE ¼ mini-mental state examination; MoCA ¼ montreal cognitive assessment;
Figure 1. ROC curve of the MVCI assessment tool for stroke. The area under curve b is
0.90 (Table 4), indicating that the probability of correctly discriminating cognitive
impairment using the MVCI assessment tool is 90.0%. Note. MVCI ¼ mild vascular
cognitive impairment; ROC ¼ receiver operating characteristic. aRandom chance line;
bROC curve.
Table 2 MVCI Assessment Tool for Stroke Devised in Present Study.
Domains Subdomains Score Items/tasks
Orientation Time & place 6 e Ask to tell current date, day of the week, season, phone number, address, & age
Memory Immediate memory 0 e Ask to repeat ﬁve words spoken by an examiner after 30 seconds
Remote/recent memory 2 e Ask to tell past history
e Ask to recall the latest events
Prospect memory 1 e Ask to recall any event (doctor's appointment, family affair, or personal affairs)
scheduled on the next day or week
Delayed memory 5 e Ask to repeat ﬁve words spoken by an examiner after a set length of time
Language Repetition 1 e Ask to repeat a sentence that can be difﬁcult to follow
Verbal ﬂuency 1 e Ask to tell more than three words start with the Korean letter “ㄱ”
Comprehension 1 e Ask to answer questions about common sense
Attention Counting numbers 2 e Ask to repeat ﬁve numbers spoken by an examiner in sequence
Calculation task 4 e Ask to count backwards from 20
e Ask to count by subtracting 7 from 100
Reasoning/abstraction Similarities 2 e Ask to explain what each pair of objects or living things has in common (animals,
ﬂowers, instruments, or modes of transportation)
e Ask to make a pair of objects (pencil & notebook)
Visuospatial ability 1 e Ask to tell the time indicated on a wall clock
Executive function/Problem solving Situation play 4 e Ask to explain how to manage a given situation commonly confronted in daily life
(4-score scale)
Total score 30
Note. MVCI ¼ mild vascular cognitive impairment.
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simplistic approach in a childish manner (2 points), 4 represented
an immature approach considering his/her age (3 points), and 5
represented a systematic and reasonable approach (4 points). Two
research assistants had practiced presenting all items to stroke
patients over a 2-week period before data collection. During this
period, the two assistants were given two typical example situa-
tions, and practiced how to categorize expected responses into the
ﬁve response options. Such pre-trainings were set up simulta-
neously for the two assistants to decrease individual differences
related to response category selection. Because the example situ-
ations were made of having deﬁnite answers, no difﬁculties in the
selection of response category were found during data collection.
To increase accuracy in assessing executive function/problem
solving ability, the two example situations were given to each study
participant and both responses were comprehensively assessed.Pretest
A pretest was conducted on ﬁve stroke patients to ensure that,
(1) it was understandable, (2) respondents could complete it within
5e10 minutes, and (3) that cognitive function scores obtained
when the MVCI assessment tool was administered face-to-face or
by telephone were similar. In general, the time period required
between two assessments is 2 weeks to avoid recall bias in healthy
adult participants. However, 1-week interval between testing via
face-to-face and telephone interview seemed to be appropriate
considering the characteristics of our participants (elderly stroke
patients who might have cognitive impairments) in the present
study.
During the pretesting, we noticed that ﬁve respondents were
sufﬁcient for pretesting purposes. The pretest was conducted by
two research assistants. One was a nursing graduate student and
the other had participated in several clinical research projects.
Pretesting indicated that the devised tool was understandable
and had no potential problems regarding the assessment of MVCI in
stroke patients. In addition, the cognitive function scores when
administered face-to-face or by telephone interview were similar.
The time taken to administer this tool during pretesting was 5e13
minutes.Study participants
The study participants comprised 60 stroke patients treated at a
university hospital located in Incheon, South Korea. Only partici-
pants who satisﬁed the following criteria were recruited: (1) stroke
diagnosed by a neurologist or neurosurgeon based on neuro-
imaging ﬁndings within 3 months of stroke onset, (2) an age of
greater than 19 years, (3) no history of previous cognitive disability,
and (4) no difﬁculty regarding voluntary handmovement (required
for drawing). Stroke patients with expressive/receptive dysphasia
were included in the present study because language ability
assessment is one of the most important purposes of a cognitive
assessment tool. The MVCI assessment tool was also designed to
test language ability.
We realized that study participants drawn from one hospital
might limit the generalizability of the results obtained. However,
the university hospital at which the data collection was conducted
had been appointed as a regional Cardio-Cerebro-Vascular Center
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hospital with respect to the treatment of acute/sub-acute stroke,
this hospital was considered appropriate in terms of regional
representativeness.
Theminimum sample size required for testing the validity of the
MVCI assessment tool for strokewas computed using theMediCalc-
13.0 program (MediCalc Software, Ostend, Belgium). The ﬁndings
obtained indicated a minimum sample size of 28 with an a value of
.05, a power (1eb) of 0.80, an area under curve (AUC) of 0.80, and a
ratio of cognitive impairment to normal cognitive function of 1.28
based on a study that reported amaximumprevalence rate of 64.0%
for vascular cognitive impairment after stroke [7]. In the present
study, AUC was used for ROC curve analysis and the value of 0.80
was derived based on an average AUC value of the MoCA
(0.75e0.85) reported by Pendlebury et al [32].
Although the minimum sample size required for the present
study was found to be 28, data was actually collected from 60
participants based on expectations of missing data and erratic re-
sponses due to cognitive impairment.
Ethical consideration
This study was approved by the human research committee of
the university the authors were afﬁliated with (IRB No.140213-1A).
We made it clear to all participants that they were free not to
participate and could withdraw from the study at any time without
prejudice. We also explained that information would be collected
anonymously and that data would be presented as mean values
(not as individual values). Study purposes and procedures were
explained and participants were then allowed to decide whether to
participate or not. Written informed consent was obtained from
patients who agreed to participate. When a patient was unable to
provide consent, written informed consent was also obtained from
family members.
Face and content validity testing
Face and content validities were tested by an expert panel
comprised of three nursing professors with experience of devel-
oping cognitive rehabilitation programs for stroke patients, and
four nurses (3 with 5e10 years of neurological intensive care unit
experience and 1 with 3 years of experience in rehabilitation
outpatient clinics). All four nurses were especially trained to
perform physical and cognitive assessments at the Cardio-Cerebro-
Vascular Center of the study university hospital for face and content
validity testing, and three were graduate students in nursing.
Face and content validities were tested by evaluating whether
cognitive domains and tasks included in the four cognitive
assessment tools (as summarized in Table 1) could properly assess
mild type cognitive impairment. In addition, the expert panel
estimated the level of difﬁculty posed by the words used in each
task or question, particularly in memory, language, and reasoning/
abstraction domains. Most items commented to be in need of
modiﬁcation by the members of the expert panel were revised.
Notably, one item assessing problem solving/executive functioning
was devised using examples of real-world situations as suggested
by the expert panel (ﬁre alarm ringing; taking cash from an ATM).
Discussions regarding discrepancies were continued until an
acceptable level of agreement was reached.
The expert panel evaluated whether completed 20 items of the
MVCI assessment tool could properly assess mild cognitive
impairment using a 3-point scale (1, not valid; 2, valid; 3, highly
valid). The content validity index (CVI) was computed as the
number of items that the experts gave a rating of either 2 or 3
divided by the total numbers of item. In the present study, the CVIof the MVCI assessment tool for stroke was 0.91, which supported
its face and content validities. That is, items of theMVCI assessment
tool for stroke appeared to be adequate for measuring band each
item corresponded with items of the other four valid cognitive
assessment tools.
Measurements for criterion validity testing
To test the criterion validity of the MVCI assessment tool for
stroke, the ﬁrst step was selecting an adequate criterion tool. Based
on reviews of related literature, we considered the MoCA to be the
most suitable measure for screening mild type cognitive impair-
ment due to its wide applicability and good validity and reliability
[29,30,32], and because it covers several cognitive domains
(orientation, language, memory, attention, abstract thinking, and
visuospatial/executive function). Accordingly, the criterion validity
of the MVCI assessment tool was examined by comparing results
obtained with those of the MoCA. The purpose of this comparison
was to examine whether the performance of the MVCI assessment
tool, which consists of written questions requiring verbal re-
sponses, matches that of the MoCA, which consists of written and
pictorial items, in terms of detecting MVCI. In addition, the MoCA
was also used to estimate a cut-off score for ROC curve analysis.
Construct validity of the original version of the MoCA was
examined by the developers [27], who reported a sensitivity of
100.0% and a speciﬁcity of 97.0% based on ROC analysis. However,
they did not determine the reliability of theMoCA. Recently, Tu et al
[28] conﬁrmed good internal consistency and inter-rater reliability
for the MoCA. The MoCA was translated into Korean by Lee et al
[29]. Since then, the validity and reliability of the Korean version
has been consistently tested [sensitivity 89.0%, speciﬁcity 84.0%,
Cronbach a ¼ .81e.84, and test-retest reliability r ¼ .75 (p < .001)].
Cronbach a of the Korean version of the MoCA in the present study
was .85.
Data collection
Data collection was performed by the two research assistants
that conducted pretesting. Both had worked as educational nurses
in a regional Cardio-Cerebro-Vascular Center and were educated
about the purposes of the present study and the structure of the
MVCI assessment tool for stroke. In addition, both had practiced
presenting all items to stroke patients over a 2-week period. To
evaluate inter-rater consistency, the two assistants independently
assessed cognitive functions of 20 stroke patients selected from the
60 study participants. Data collection was conducted in patient
rooms or outpatient clinics.
Data analysis
Statistical analysis was performed using SPSS/PC version 21.0
(IBM SPSS Statistics-Korea, Seoul, Korea). Descriptive analysis was
used to describe general subject characteristics andmajor variables.
Content and criterion (concurrent) validities of the MVCI assess-
ment tool for stroke were evaluated using CVI values and by cor-
relation analysis, respectively.
In general, factor analysis, known group method, multitrait
multimethod, or nomological analysis can be used to examine
construct validity of a measurement tool [33,34]. Although the
most frequently used method to examine construct validities is
factor analysis, it was not considered appropriate for the present
study because four domains (attention, reasoning/abstraction, vi-
suospatial ability, and executive function/problem solving) of the
MVCI assessment tool consist of only one or two items.
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the characteristics of a measurement tool. For a binary classiﬁer,
such as the presence or absence of a particular disease (MVCI in the
present study), it is important to select optimal cut-off values. In
this context, ROC curve analysis offers a powerful means of evalu-
ating the performance of a binary classiﬁer and for determining
cut-off values [29,32]. In the present study, ROC curve analysis was
conducted to determine optimal cut-off values and the sensitivity/
speciﬁcity (construct validity) of the MVCI assessment tool for
stroke.
Using ROC curve analysis, we calculated the AUCs, sensitivities,
speciﬁcities, positive predictive values (PPVs), and negative pre-
dictive values (NPVs) of different candidate cut-off scores. To test
the reliability of the MVCI assessment tool, its internal consistency
and inter-rater reliability were evaluated using Cronbach a and
Spearman r, respectively.Results
Descriptive statistics of participant characteristics
Mean age of the 60 study participants was 64.07 years (± 13.46),
and 48 (80.0%) weremale and 12 (20.0%) female. Overall, 23 (38.4%)
participants had lesions of the basal nuclei, 9 (15.0%) of the pons, 8
(13.3%) of the right/left middle cerebral artery, 5 (8.3%) of the cer-
ebellum, 3 (5.0%) of the diencephalon, 3 (5.0%) of the parietal lobe,
and 9 (15.0%) of other areas (subarachnoidal hemorrhage, intra-
ventricular hemorrhage, right/left posterior cerebral artery, and
multiple infratentorial infarction). Eleven (18.3%) of the study par-
ticipants had hematoma and the mean amount of bleeding was
27 mL (± 8.72). Regarding surgical modalities related to stroke, 3
patients (5.3%) underwent surgery, such as craniotomy, clipping, or
coiling (Table 3).
Brain injury severity was assessed using the Glasgow Coma
Scale (GCS) or the National Institute of Health Stroke Scale
(NIHSS), as determined by the department involved. The GCS and
NIHSS were applied to 23.3% and 77.6% of the participants,
respectively. The mean GCS and NIHSS scores at admission were
[12.21 (± 3.07)/16] and [6.06 (± 4.23)/42], respectively, indicating
moderate severity. Mean cognitive impairment scores deter-
mined using the MVCI assessment tool for stroke and the MoCA
were [22.39 (±6.04)/30] and [22.69 (± 6.48)/30], respectively
(Table 3).Table 3 Descriptive Statistics for Participant Characteristics.
Variables Frequencies (%)/M ± SD
Age 64.07 ± 13.46
Site of lesion Basal ganglia 23 (38.4)
Pons 9 (15.0)
MCA 8 (13.3)
Cerebellum 5 (8.3)
Diencephalon 3 (5.0)
Parietal lobe 3 (5.0)
Elsea 9 (15.0)
Size of hematoma (mL) 27.00 ± 8.72
Scales used for assessing severity GCS 14 (23.3)
NIHSS 46 (76.6)
MVCI score 22.39 ± 6.04 (total 30)
Note. GCS ¼ glasgow coma scale; MCA ¼ right/left middle cerebral artery; MoCA ¼ mon
tool for Stroke; NIHSS ¼ national institutes of health stroke scale.
a Including subarachnoid hemorrhage; intraventricular hemorrhage; right/left posteri
b Including craniotomy, clipping, and coiling surgery.Criterion validity testing
The criterion validity test is widely used to establish the validity
of measurement tools. In general, criterion validity can be
demonstrated by comparing the selected measure with another
valid measure; similarity between measures can be quantiﬁed us-
ing correlation coefﬁcients. The correlation coefﬁcient between the
cognitive impairment scores determined using the MVCI assess-
ment tool and the MoCA was 0.88 (p  .001), indicating a high
degree of correlation (Table 4). Domain scores in orientation
(r ¼ .79, p  .001), memory (r ¼ .62, p  .001), language (r ¼ .70,
p  .001), attention (r ¼ .81, p  .001), and visuospatial ability
(r ¼ .63, p  .001) were found to be signiﬁcantly related between
the two scales (Table 4).
Construct validity and clinical adequacy testing
ROC curve analysis was conducted to evaluate the construct
validity and the clinical adequacy of the MVCI assessment tool for
stroke. A potential cut-off score for MVCI was estimated based on
cut-offs reported for the MoCA, which ranged from 21 to 27
[28,35e37], and averaged 24. Accordingly, participants with an
MVCI score 24 or 23were allocated a normal cognitive function
group or a cognitive impairment group.
AUCs provide a numerical summary of ROC curves, and are
considered suitable for quantifying the abilities of measurement
tools to differentiate disease and nondisease states (i.e., MVCI and
normal cognitive function in the present study). AUC values can be
interpreted as probabilities, and range from 0.5 (incapable of
discriminating) to 1.0 (perfect ability to discriminate). In the pre-
sent study, the AUC of theMVCI assessment tool for strokewas 0.90
with a 95% conﬁdence interval (CI) of 0.78e1.00 (p  .001, Table 4,
Figure 1), indicating a probability of correctly identifying MVCI of
90%, which is considered excellent [38].
To determine the optimal cut-off score for the MVCI assessment
tool for stroke, its sensitivities, speciﬁcities, PPVs, and NPVs at
candidate cut-off points of 23 and 24 (from the average cut-off
score of the MoCA) were determined. At a cut-off of 23, its sensi-
tivity was 0.92, speciﬁcity was 0.89, PPV was 93.5% (95% CI [80.29,
98.96]), and NPVwas 86.6% (95% CI [65.35, 97.19]). At a cut-off of 24,
its sensitivity was 0.82, speciﬁcity was 0.89, PPV was 92.8% (95% CI
[78.17, 98.86]), and NPV was 74.1% (95% CI [53.35, 89.16]) (Table 4).
Because of its higher sensitivity, we subsequently used a score of 23
as the optimal cut-off.Variables Frequencies (%)/M ± SD
Gender Male 48 (80.0)
Female 12 (20.0)
Presence of hematoma Yes 11 (18.3)
No 49 (81.7)
Surgery Yesb 3 (5.3)
No 57 (94.7)
Level of severity GCS 12.21 ± 3.07 (total 16)
NIHSS 6.06 ± 4.23 (total 42)
MoCA score 22.69 ± 6.48 (total 30)
treal cognitive assessment; MVCI ¼ mild vascular cognitive impairment assessment
or cerebral artery; multiple infratentorial infarction;
Table 4 Validity, Reliability, and Clinical Adequacy of the MVCI Assessment Tool for Stroke.
Test Types Statistical Methods Statistics
Validity Criterion validity Correlational analysis Overall: r ¼ .88 (p  .001)
Orientation: r ¼ .79 (p  .001)
Memory: r ¼ .62 (p  .001)
Language: r ¼ .70 (p  .001)
Attention: r ¼ 0.81 (p  .001)
Visuospatial: r ¼ .63 (p  .001)
Reliability Internal consistency Correlational analysis (item total correlation) r ¼ .48e.74
Reliability analysis (Cronbach a) a ¼ .89
Inter-rater reliability Nonparametric correlational analysis
(Spearman r)
r ¼ 0.93 (p  .001)
Clinical adequacy Discriminant ability ROC curve analysis
AUC (p) Cut-off value Sensitivity Speciﬁcity PPV (95% CI) NPV (95% CI)
0.90 (< .001)  23 0.92 0.89 93.5 [80.3, 99.1] 86.6 [65.4, 97.2]
 24 0.82 0.89 92.8 [78.2, 98.9] 74.1 [53.4, 89.2]
Note. AUC ¼ area under curve; CI ¼ conﬁdence interval; MVCI ¼ mild vascular cognitive impairment; NPV ¼ negative predictive value; PPV ¼ positive predictive value;
ROC ¼ receiver operating characteristic.
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The internal consistency of the MVCI assessment tool for stroke
was well supported by the present study. The inter-total correlation
for the 20 items ranged from .48 to .74, and most values were above
the critical value of .40 of the summated rating scale [39]. Cronbach
a (a coefﬁcient of internal consistency) was high at .89, while its
inter-rater reliability was conﬁrmed by a Spearman r of 0.93
(p  .001, Table 4).
Discussion
According to Leys, Henon, Mackowiak-Cordoliani, and Pasquier
[40], the prevalence of poststroke dementia ranges from 21.0% to
32.0%, which is higher than the prevalence of nonstroke dementia
(11.0%) [41]. Furthermore, the risk of dementia is markedly
increased after recurrent stroke [26]. Dementia can be easily
detected because it affects the activities of daily life, but mild
cognitive impairment is often difﬁcult to diagnose [18]. According
to Jin et al [7], 64.0% of stroke survivors had some form of cognitive
impairment, and usually this amounts to a mild type of cognitive
impairment. Furthermore, individuals with mild impairments
progress to dementia faster than age-matched healthy controls
[42].
In the present study, we developed the 20-item MVCI assess-
ment tool, which can be administered face-to-face or by telephone
interviews to enable long-term follow-up assessments, based on
previously veriﬁed cognitive assessment tools. The items were
designed to assess seven cognitive domains that have been
consistently reported to be affected by stroke [25,26,43]. These
seven domains include orientation, language, attention, memory,
executive function and problem solving, reasoning/abstraction, and
visuospatial ability.
According to Oh and Seo [31], stroke patients may experience
diverse types of mild cognitive disabilities that involve impair-
ments of language, memory, problem solving, and/or safety and
social behavior. In this previous study, mild cognitive impairments
were found in 23.3%e35.4% of patients during the ﬁrst month after
stroke, and at 6months after stroke, the proportion of patients with
a language or memory impairment decreased to 6.1%e10.2%, but
the proportion with a problem solving, safety behavior, or social
behavior impairments remained high (20.2%e20.4%). Oh and Seo
[31] concluded that such differences in recovery rates might be
related, in part, to levels of complexity, that is, more complex
cognitive abilities, such as, problem solving, safety behavior, and
social behavior, are probably more severely affected after stroke.In the present study, the validity of theMVCI assessment tool for
stroke was examined using content, face, and criterion validity
tests. An expert panel conducted content and face validity testing
and found that all 20 items were adequate for measuring MVCI.
Each item corresponded with the conceptual deﬁnition of post-
stroke cognitive impairment and with the items of other valid
cognitive assessment tools, which indicated that the content and
face validities of the MVCI assessment tool for stroke were well
supported.
The criterion validity of the MVCI assessment tool for stroke was
tested by comparing its results with those of the MoCA, which was
used as a criterion tool due to its relatively good sensitivity for
detecting mild type cognitive impairment and its ability to assess
diverse cognitive domains associated with stroke [11,36]. In the
present study, we found cognitive scores determined by the MVCI
assessment tool and MoCA were highly correlated.
ROC curve analysis was conducted to assess the clinical ade-
quacy of the MVCI assessment tool for stroke. Initially, we consid-
ered using a cut-off score of 24, whichwas the average of previously
reported MoCA cut-off values. However, at a cut-off of 23, the
fractions of participants with MVCI that the MVCI assessment tool
correctly identiﬁed as having such a condition was 92.0% (sensi-
tivity of 0.92), and the fractions of participants with normal
cognitive function that the MVCI assessment tool correctly identi-
ﬁed as having normal cognitive function was 89.0% (speciﬁcity of
0.89). In addition, the overall probability of correctly diagnosing
MVCI using the MVCI assessment tool for stroke was 90.0%. On the
other hand, when a cut-off of 24 was used, sensitivity decreased to
0.82, but speciﬁcity was maintained (0.89).
At a cut-off of 23, 93.5% (PPV) of the participants with cognitive
impairment (identiﬁed using the MVCI assessment tool) were
found to actually have cognitive impairment (identiﬁed using the
MoCA). In addition, 86.6% (NPV) of the participants with normal
cognitive function (identiﬁed using the MVCI assessment tool)
were found to actually have normal cognitive function (identiﬁed
using the MoCA). On the other hand, at a cut-off of 24, PPV and NPV
were markedly reduced to 92.7% and 74.1%, respectively. Based on
these ﬁndings, a score of 23 was taken to be an optimal cut-off with
respect to sensitivity and speciﬁcity.
Pendlebury et al [37] reported a sensitivity and speciﬁcity of
77.0% and 83.0%, respectively, for the detection of mild cognitive
impairment using the MoCA at a cut-off score of 25. Theses authors
also reported a sensitivity and speciﬁcity of 83.0% and 73.0%,
respectively, for Addenbrooke's Cognitive Examination Revised
(ACE-R), at a cut-off score of 94. These ﬁndings demonstrate that
the sensitivities and speciﬁcities of the MoCA and ACE-R for
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using the MVCI assessment tool for stroke devised in the present
study. Pendlebury et al [37] detected mild cognitive impairment
using the Neuropsychological Assessment Battery, whereas we
used the average cut-off score of the MoCA, and this difference
between the criteria used to diagnose mild cognitive impairment
may have contributed to the sensitivity and speciﬁcity differences
observed between the two studies. The Neuropsychological
Assessment Battery used by Pendlebury et al [37] assesses execu-
tive function, attention, language, visuospatial, and memory do-
mains, and includes six speciﬁc tests (the Trail Test, the Symbol
Digit Modalities Test, the 30-item Boston Naming Test, the Rey-
Osterrieth Complex Figure Copy Test, the Hopkins Verbal
Learning TesteRevised, and letter and category ﬂuency tests) and
takes approximately 50e60 minutes to apply. Accordingly, it is
considerably more complex and probably more accurate at
detecting mild cognitive impairment than the MVCI assessment
tool for stroke.
In the present study, 63.0% of the 60 stroke patients were found
to have mild cognitive impairment according to the MVCI assess-
ment tool, which concurs with the rate determined by Jin et al [7],
who found that 64.0% of stroke survivors had cognitive
impairment.
Nursing implication
The early detection of MVCI in stroke patients is important for
facilitating intervention, delaying or preventing the onset of de-
mentia, and for developing effective cognitive rehabilitation plans
that improve outcomes and quality of life. A well-validated cogni-
tive assessment tool containing accurate and simple items would
beneﬁt nursing care and the development of rehabilitation plans
for stroke patients in acute and subacute stages. To meet such
needs, we designed to the MVCI assessment tool for stroke, which
can be completed in only 10 minutes but yet addresses the major
cognitive domains associated with stroke. Our ﬁndings showed
that theMVCI assessment tool for stroke has excellent criterion and
construct validity and relevant clinical applicability with high
sensitivity and speciﬁcity. We believe that the MVCI assessment
tool offers clinically useful means for detecting MVCI and for
properly assessing degrees of cognitive impairment in stroke pa-
tients. In addition, the 20 items of the MVCI assessment tool are
written questions requiring verbal responses. This allows the MVCI
assessment tool to be administered over the telephone or by face-
to-face interview, and thus, facilitate longitudinal follow-up ex-
aminations of patterns of cognitive changes after stroke.
Conclusion
The present study was conducted to develop an MVCI assess-
ment tool for stroke and to determine its validity, reliability, and
clinical adequacy. The 20 items of the MVCI assessment tool for
stroke were developed based on valid, pre-existing cognitive
assessment tools, and designed to assess seven cognitive domains
including orientation, memory, language, attention, reasoning/
abstraction, visuospatial perception, and executive function/prob-
lem solving. The present study supports the content, face, and
construct validities of the MVCI assessment tool for stroke. Clinical
adequacy testing revealed that the overall probability of correctly
discriminating vascular cognitive impairment using the MVCI
assessment tool for stroke was 90.0%, which was statistically sig-
niﬁcant. A score of 23 was found to be an optimal cut-off point for
maximizing in sensitivity and speciﬁcity. Our evaluation of the
reliability supported its internal consistency and inter-rater reli-
ability. Furthermore, our ﬁndings indicate that the MVCIassessment tool for stroke offers a clinically useful means for
detecting MVCI and for properly assessing degrees of vascular
cognitive impairment in stroke patients.
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